Results 91 to 100 of about 1,271,529 (341)

Zooming‐in – Visualization of active site heterogeneity in high entropy alloy electrocatalysts using scanning electrochemical cell microscopy [PDF]

open access: gold, 2021
Emmanuel Batsa Tetteh   +10 more
openalex   +1 more source

On entropy, entropy-like quantities, and applications

open access: yesDiscrete & Continuous Dynamical Systems - B, 2015
35 pages, no figures.
Amigó, José   +2 more
openaire   +3 more sources

The concavity of R\`enyi entropy power

open access: yes, 2012
We associate to the p-th R\'enyi entropy a definition of entropy power, which is the natural extension of Shannon's entropy power and exhibits a nice behaviour along solutions to the p-nonlinear heat equation in $R^n$.
Savarè, Giuseppe, Toscani, Giuseppe
core   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Entropy of the FRW cosmology based on the brick wall method

open access: yes, 2008
The brick wall method in calculations of the entropy of black holes can be applied to the FRW cosmology in order to study the statistical entropy. An appropriate cutoff satisfying the covariant entropy bound can be chosen so that the entropy has a ...
't Hooft   +35 more
core   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Nanoprecipitate‐Strengthened High‐Entropy Alloys

open access: gold, 2021
Liyuan Liu   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy